international pharmaceutical compliance congress
international pharmaceutical compliance congress
international pharmaceutical compliance congress
international pharmaceutical compliance congress
international pharmaceutical compliance congress
international pharmaceutical compliance congress
Press Release: Tenth International Pharma Compliance Congress Features Chief Compliance Officers Roundtable
  • A Hybrid Conference and Internet Event
  • Sponsored by ETHICS, the International Society of Healthcare Compliance Professionals
  • Co-sponsored by the Pharmaceutical Compliance Forum
  • May 10 - 12, 2016
  • Onsite at the Hilton Warsaw Hotel and Convention Centre in Warsaw, Poland
  • In Your Own Office or Home live via the Internet with 24/7 Access for Six Months
  • www.InternationalPharmaCongress.com
PRESS RELEASE
Phone: 800-503-8171
Email: registration@hcconferences.com
Website: www.InternationalPharmaCongress.com
CHIEF COMPLIANCE OFFICER ROUNDTABLE

Dante Beccaria
Global Compliance Officer and Vice President, Sanofi, Former Vice President of Internal Audit, Sanofi, Paris, France

Eric Cornut, LLM
Chief Ethics, Compliance & Policy Officer, Novartis, Former Chief Commercial Officer, Novartis, Basel, Switzerland

Marc-Olivier Lamaro
Chief Compliance Officer, Sanofi Pasteur MSD, Former Director, Compliance Officer, Johnson & Johnson, Lyon, France

Lori V. Queisser
Senior Vice President and Global Compliance Officer, Teva Pharmaceuticals, Former Sr. VP Global Compliance and Business Practices, Schering-Plough, Former Vice President and Chief Compliance Officer, Eli Lilly, Philadelphia, PA, USA

Uffe Kåre Rasmussen, M.Sc.
Senior Director and Chief Compliance Officer, H. Lundbeck A/S, Former Principal Scientist, Novo Nordisk A/S, Copenhagen, Denmark

Kip Ebel, MBA
Principal, Fraud Investigation & Dispute Services, EY, New York, NY, USA (Moderator)

WARSAW, POLAND -- PHARMA UPDATE NEWS SERVICE™ -- JANUARY 19, 2016: The Tenth International Pharmaceutical Compliance Congress, www.InternationalPharmaCongress.com, to be held on May 10 - 12, 2016 at the Hilton Warsaw Hotel and Convention Centre in Warsaw, Poland, today announced the conference dates and a call for presentation proposals.



KEYNOTE SPEAKERS

Sadek Beloucif, MD
Professor, Department of Anesthesiology and Critical Care Medicine, Avicenne University Hospital, Chairman, Ethics Committee of the Biomedicine Agency, Paris, France

Hui Chen, JD
Compliance Counsel Expert, US Department of Justice, Former Global Head, Anti-Bribery and Corruption, Standard Chartered Bank, Former Assistant General Counsel, Pfizer, Washington, DC, USA

Gejaa Gobena, JD
Chief, Health Care Fraud Unit, US Department of Justice, Washington, DC, USA

Jose F. Zamarriego Izquierdo
Director Unidad de Supervision Deontologica, FARMAINDUSTRIA, Madrid, Spain

Sophie Peresson
Director, Pharmaceuticals & Healthcare Programme, Transparency International UK, London, UK

Marie-Claire Pickaert
Deputy Director General and Chief Financial Officer, European Federation of Pharmaceutical Industries and Associations (EFPIA), Brussels, Belgium

Heather Simmonds
Director, Prescription Medicines Code of Practice Authority; Vice-Chair, IFPMA Code Compliance Network, London, UK

CHIEF COMPLIANCE OFFICER ROUNDTABLE

Dante Beccaria
Global Compliance Officer and Vice President, Sanofi, Former Vice President of Internal Audit, Sanofi, Paris, France

Eric Cornut, LLM
Chief Ethics, Compliance & Policy Officer, Novartis, Former Chief Commercial Officer, Novartis, Basel, Switzerland

Marc-Olivier Lamaro
Chief Compliance Officer, Sanofi Pasteur MSD, Former Director, Compliance Officer, Johnson & Johnson, Lyon, France

Lori V. Queisser
Senior Vice President and Global Compliance Officer, Teva Pharmaceuticals, Former Sr. VP Global Compliance and Business Practices, Schering-Plough, Former Vice President and Chief Compliance Officer, Eli Lilly, Philadelphia, PA, USA

Uffe Kåre Rasmussen, M.Sc.
Senior Director and Chief Compliance Officer, H. Lundbeck A/S, Former Principal Scientist, Novo Nordisk A/S, Copenhagen, Denmark

Kip Ebel, MBA
Principal, Fraud Investigation & Dispute Services, EY, New York, NY, USA (Moderator)

GLOBAL ANTICORRUPTION UPDATE

Ted Acosta, Esq.
Americas Vice Chair, Risk Management and Global Leader, Life Sciences, Fraud Investigation and Dispute Services, EY, Former Senior Counsel, Office of Inspector General, US Department of Health and Human Services, New York, NY, USA and Paris, France

Gary F. Giampetruzzi, Esq.
Partner, Paul Hastings, Former Vice President and Assistant General Counsel, Head of Government Investigations, Pfizer Inc., New York, NY, USA

Michael K. Loucks, Esq.
Partner, Skadden Arps LLP, Former Acting United States Attorney, District of Massachusetts, United States Department of Justice, Washington, DC, USA

Paul J. Melling, Esq.
Founding Partner, Baker & McKenzie - CIS, Limited, Moscow, Russia

Vivian Robinson, Esq.
Queen's Counsel, Partner, McGuire Woods, Former General Counsel of the UK Serious Fraud Office, Former Head, QEB Hollis Whiteman Chambers, Recorder of the Crown Court and Treasurer of Inner Temple, London, UK

FEATURED FACULTY

Andy Bender, MS, MBA
President and Founder, Polaris, New York, NY

Pierre E. Dupourque, JD
Assistant General Counsel, Regional Compliance Lead EMEA, Canada, Pakistan, India, Pfizer, Mannheim, Germany

Sue Egan
Director and Principal Consultant, Sue Egan Associates, Former Vice President Compliance, AstraZeneca, Great Missenden, Buckinghamshire, UK

Cécile Gousset
Associate Vice President, Compliance Risk Assessment, Education and Monitoring, Global Ethics & Business Integrity, Sanofi, Paris, France

Keith M. Korenchuk, JD, MPH
Partner, Arnold & Porter LLP, Washington, DC

Tomasz Kruk, MBA, LLM
Head of Compliance, Vifor Pharma, Former Director International Compliance, Mallinckrodt Pharmaceuticals, Former Director Global Ethics & Compliance, Actavis plc (now Allergan plc), Zürich, Switzerland

Maurits J.F. Lugard, MA, JD, LLM
Partner and Lead, EU Life Sciences Regulatory Team, Sidley Austin LLP, Former Member of the European Commission's Legal Service, Brussels, Belgium

David O'Shaughnessy
Vice President, Compliance, Emerging Markets, Quintiles, Board Member, ETHICS, Former Vice President Compliance, International Pharmaceuticals, GSK, Former Vice President, Global Compliance Strategy, AstraZeneca, Reading, UK

Piergiorgio Pepe, LLB
EEMEA Director, Ethics and Compliance, AbbVie, Former Director, Compliance and Ethics, EMEA, Bristol-Myers Squibb, Paris Area, France

Nathalie Raynaud
Corporate Compliance Officer, Ethics & Business Integrity Department, Sanofi, Paris, France

Michele Tagliaferri, Esq.
Partner, Sidley Austin LLP, Brussels, Belgium

Dr. Mirjam Weisse, JD
Senior Director, Head of Compliance EMEA, Merz Pharma GmbH & Co, KGaA, Frankfurt, Germany

Andrew White
Head of Medicine Management - NHS, Greater Manchester Commissioning Support Unit, Manchester, UK

Mariusz Witalis
Partner, Fraud Investigation and Dispute Services, Ernst & Young LLP, Warsaw, Poland

Olivier Wong, MD
Specialist in Family Medicine; Former Voting Member, French Transparency Committee, Paris, France

Elisabethann Wright, Esq.
Partner, Hogan Lovells, Former Senior Legal Officer and Hearing Officer, EFTA Surveillance Authority, Brussels, Belgium

Jolanta Wyszynska
Vice President Compliance Europe, AstraZeneca, Warsaw, Poland

Milena Yakimova, LLM
Director Ethics & Compliance, Central and South East Europe, Allergan, Sofia, Bulgaria

OTHER GLOBAL PHARMA CONGRESS CITIES

2007 - Brussels


2008 - Paris


2009 - Rome


2010 - Berlin


2011 - Istanbul

2011 - Singapore


2012 - Budapest


2012 - Shanghai


2012 - São Paulo


2013 - Madrid

2013 - Kuala Lumpur


2014 - Dubai


2014 - Mexico City


2014 - Shanghai


2015 - Manila



SPEAKER PRESENTATION PROPOSALS
Speaker/Presentation Proposals for the International Pharma Congress May Be Submitted Through Our Online Form
- Click Here -
SPONSORED BY:


CO-SPONSORS:




CO CHAIRS

Dr. Michael Bartke
Director Compliance Management, DAIICHI SANKYO EUROPE GmbH, Munich, Germany

Ann Beasley
Chief Compliance Officer, Biogen, Former Global Compliance Officer, Novartis Pharma AG, Board Member and Co-chair, Strategic Committee International Society of Healthcare, Ethics, and Compliance Professionals (ETHICS), Cambridge, MA, USA

Stephen Nguyen Duc
Office of Ethics & Compliance Area Director, International Operations, Western Europe & Canada, AbbVie, Rungis, France

Dominique Laymand, Esq.
Senior Vice President, Chief Ethics and Compliance Officer, Ipsen; President, International Society of Healthcare Ethics and Compliance Professionals (ETHICS), Paris, France

Roeland Van Aelst
Regional Vice President - HCCO MD&D EMEA & Canada, Office Health Care Compliance and Privacy, Johnson & Johnson, Co-chair, Strategic Committee, International Society of Healthcare, Ethics and Compliance Professionals (ETHICS), Chairman, MedTech Compliance Network, Brussels, Belgium

GRANTORS:
DIAMOND


BRONZE


















FOLLOW INTERNATIONAL PHARMA CONGRESS ON




Tweet using #PharmaCongress

INTERNATIONAL PHARMA CONGRESS IS


PARTICIPATION OPTIONS
TRADITIONAL ONSITE ATTENDANCE
Simply register, travel to the conference city and attend in person.

Pros: subject matter immersion; professional networking opportunities; faculty interaction


LIVE AND ARCHIVED WEBCAST PARTICIPATION
Watch the conference in live streaming video over the Internet and at your convenience at any time 24/7 for the six months following the event.

The archived conference includes speaker videos and coordinated PowerPoint presentations.

Pros: Live digital feed and 24/7 Internet access for next six months; Accessible in office, at home or anywhere worldwide with Internet access; Avoid travel expense and hassle; No time away from the office





WEBCAST INTERFACE SAMPLE

Click here for a sample stream

2016 GLOBAL PHARMA COMPLIANCE CONGRESSES

SEVENTEENTH PHARMACEUTICAL REGULATORY AND COMPLIANCE CONGRESS
A Hybrid Conference and Internet Event
Transformational Learning - Effective Knowledge Exchange
Sponsored by Pharmaceutical Compliance Forum
Media Partners: Harvard Health Policy Review, Health Affairs and Life Sciences Compliance Update
October 19 - 21, 2016
Mandarin Oriental
Washington, DC
www.PharmaCongress.com
SIXTH ASIA PACIFIC PHARMACEUTICAL
COMPLIANCE CONGRESS

A Hybrid Conference and Internet Event
Sponsored by Asia Pacific Healthcare Industry Compliance Team
Cosponsored by International Society of Healthcare Ethics and Compliance Professionals (ETHICS) and Pharmaceutical Compliance Forum (PCF)
Media Partners: Life Sciences Compliance Update
September 21 - 23, 2016
Shangri-La Hotel
Singapore
www.AsianPharmaCongress.com
PHARMACEUTICAL SUMMIT ON BUSINESS
AND COMPLIANCE ISSUES IN MANAGED MARKETS

The Leading Forum on Pharmaceutical Market Access, Reimbursement, Pricing, and Contracting with Commercial and Government Payers
Co-located with Eighth National Medical Home, Sixth Bundled Payment Summit and Seventh National ACO Summit
Media Partners: Harvard Health Policy Review, Health Affairs and Life Sciences Compliance Update
June 8 - 9, 2016
Grand Hyatt
Washington, DC
www.PharmaManagedMarketsSummit.com

CONGRESS REGISTRATION

For Congress registration information, visit www.InternationalPharmaCongress.com/registration.php, email registration@hcconferences.com, or call 800-503-8171.


CONGRESS EXHIBIT & SPONSORSHIP INFORMATION
For sponsorship and exhibit information, visit www.internationalpharmacongress.com/promotional/index.html, or contact Justin Sorensen, Exhibit Manager, at 206-452-0609 phone, 206-319-5303 fax, or exhibits@hcconferences.com.